Tickerplace logo

Tickerplace

Clinuvel Pharmaceuticals Limited logo

CUVClinuvel Pharmaceuticals Limited

CUV Stock Price, Valuation & Chart | Clinuvel Pharmaceuticals Limited

Compare
$7.560+0.24 (+3.28%)

At close · 16 Oct 2026, 05:10 am

Sector: HealthcareIndustry: BiotechnologyWebsite
OverviewFinancialsDividendsRatios

CUV Historical price chart

CUV Key Stats

Market Capitalization381.68M
PE Ratio11.05
EPS0.68
Trading Volume88.70K
Today's High/Low7.65/7.14
Dividend Yield0.50
52 Week High/Low13.48/7.08
Shares Outstanding50.49M
CUV Financial Statement

CUV Analyst ratings

Buy

Strong buy
1
Buy
7
Hold
0
Sell
0
Strong sell
0

Based on 8 analysts giving stock ratings to CUV in the past 3 months.

CUV Analysis & performance metrics

CUV Company profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening…

CUV Management team

Management
Peter VaughanCFO
Chief Financial Officer
Claire Newstead-Sinclair C.A.
Company Secretary
Dennis J. Wright BPharm, M.Sc., Ph.D.
Chief Scientific Officer
Rose Quadbeck-Diel
Senior Vice President of Regulatory Affairs
Azza Hamila
Head of Quality Assurance & Drug Safety
Philippe Jacques Wolgen M.B.A., M.D.CEO
Chief Executive Officer, MD & Director
Lachlan Hay
Chief Operations Officer
Malcolm Bull
Head of Australian Operations & Investor Relations
Total 8 executives

CUV Frequently asked questions

What is Clinuvel Pharmaceuticals Limited (CUV) Stock Price?

Current stock price of Clinuvel Pharmaceuticals Limited (CUV) stock is $7.560. The stock price is +3.28% higher in the session. The intraday range can be seen from this page. Volume of Clinuvel Pharmaceuticals Limited (CUV) stock is 88.70K.

Last updated at 16 Oct 2026, 05:10 am.

Why is the Clinuvel Pharmaceuticals Limited (CUV) stock price going up or down today?

The stock price of Clinuvel Pharmaceuticals Limited (CUV) can change with earnings, company news, and overall market sentiment. Clinuvel Pharmaceuticals Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Clinuvel Pharmaceuticals Limited stock expensive at its current price?

Whether Clinuvel Pharmaceuticals Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CUV on this page is 11.05. EPS on this page is 0.68. Compare those figures with peers and growth expectations before deciding if the current Clinuvel Pharmaceuticals Limited price is justified.

How has the stock price of Clinuvel Pharmaceuticals Limited (CUV) performed historically?

Historical performance for Clinuvel Pharmaceuticals Limited (CUV) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CUV reacted to past earnings and market events.

Should I buy Clinuvel Pharmaceuticals Limited (CUV) stock, at this price?

Buying Clinuvel Pharmaceuticals Limited (CUV) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.